Adverse events
| Adverse events, n (%) . | Grade 1/2 . | Grade 3/4 . |
|---|---|---|
| Patients with ≥1 events | 16 (88.9) | 7 (38.9) |
| Neutropenia | 3 (16.7) | 3 (16.7) |
| Thrombocytopenia | 2 (11.1) | 6 (33.3) |
| Anemia | 1 (5.6) | 0 |
| Infections and infestations | 5 (27.8) | 2 (11.1) |
| Nausea and vomiting | 8 (44.4) | 0 |
| Fatigue and weakness | 5 (27.8) | 0 |
| Anorexia | 3 (16.7) | 0 |
| Headache | 3 (16.7) | 0 |
| Rash | 2 (11.1) | 0 |
| Abdominal pain | 2 (11.1) | 0 |
| Acute GVHD | 2 (11.1) | 0 |
| Diarrhea | 2 (11.1) | 0 |
| Elevated bilirubin | 1 (5.6) | 0 |
| Fever | 1 (5.6) | 0 |
| Adverse events, n (%) . | Grade 1/2 . | Grade 3/4 . |
|---|---|---|
| Patients with ≥1 events | 16 (88.9) | 7 (38.9) |
| Neutropenia | 3 (16.7) | 3 (16.7) |
| Thrombocytopenia | 2 (11.1) | 6 (33.3) |
| Anemia | 1 (5.6) | 0 |
| Infections and infestations | 5 (27.8) | 2 (11.1) |
| Nausea and vomiting | 8 (44.4) | 0 |
| Fatigue and weakness | 5 (27.8) | 0 |
| Anorexia | 3 (16.7) | 0 |
| Headache | 3 (16.7) | 0 |
| Rash | 2 (11.1) | 0 |
| Abdominal pain | 2 (11.1) | 0 |
| Acute GVHD | 2 (11.1) | 0 |
| Diarrhea | 2 (11.1) | 0 |
| Elevated bilirubin | 1 (5.6) | 0 |
| Fever | 1 (5.6) | 0 |